Abstract: Polymers have a long history in medicine. Their uses to date range from traditional applications such as catheters, syringes, blood contacting extra corporeal devices to matrices for drug delivery, cell encapsulation and tissue regeneration. Polymers can be broadly classified on the basis of the reactivity of their chemical backbone (or susceptibility of the backbone to breakdown upon exposure to water, i.e., hydrolysis) as non-degradable and degradable. In this review, the polymers that exhibit no to very low degradation in aqueous and biological environments will be covered. The applications of various polymers both in traditional and emerging medical areas is discussed in the context of its chemical structure to better enable material selection for biomedical research.
INTRODUCTION
Synthetic polymers have found extensive applications in the biomedical arena. The spectrum of applications includes but are not limited to:
. Coatings on devices (e.g., to improve blood compatibility)
. Devices (e.g., implantable drug delivery systems, artificial heart) . Implants (e.g., bone pins and screws, articulating surface in artificial joints)
. Catheters Injectable drug delivery systems and tissue engineering, which have emerged in the past two decades, constitute some of the recent applications for synthetic polymers.
Due to the vast body of literature in the biomedical uses of synthetic polymers, detailed treatment of each system is beyond the scope of this review. Instead, the focus will be on presenting a broad perspective of the past, present and future of the role of an important sub-class of synthetic polymers namely the non-degradable systems. Whenever possible important clinical findings are highlighted and good recent reviews have been referred to. The purpose of this review article is to provide a brief overview of some of the major polymers in medicine and not to serve as a substitute for original research articles and more exhaustive reviews of specific families of polymers or their uses. The central theme in this review is the exploitation of a specific material *Address correspondence to this author at the 3231 Walnut Street, Philadelphia, PA 19104, USA; E-mail: shastriv@seas.upenn.edu property vis-à-vis a clinical or biological problem. Table 1 provides a list of some of the most commonly used synthetic polymers in medicine, their chemical structure, trade names, key properties, and uses.
PAST AND PRESENT USES
One of the major driving forces in use of polymers in medicine has been the need to find functional replacements for failing body parts. Skeletal reconstruction has by far seen the most polymer use to date. The choice of the polymer is based on several considerations such as mechanical strength, ease of processing, inertness in a biological environment, abrasive resistance, wear-tear characteristics, bloodcompatibility, tissue adhesivity and permeability to oxygen among others. Which property will dominate the selection criteria is dictated by the interplay between the above mentioned variables in the context of a particular application. For example, in choosing a material for vascular grafting anti-coagulative characteristics would be a dominating factor along with compliance. Likewise, in facial reconstruction applications moldability and inertness will be dominating considerations.
The property of polymers is dictated by the nature of the chemical bonds that make up the polymer backbone, which is a function of the chemistry of the building blocks, namely the monomer unit and the linkages between the monomers [1] . In general a carbon-carbon bond is chemically and biological quite inert. The inert nature of the C-C bond can be modulated by oxidation of the carbon backbone. Therefore, an ester and urethane bond is more likely to degrade than a ketone or a sulfone bond; which is more likely to degrade than an ether bond [2] . Furthermore, with respect to processibility and mechanical properties, increasing the oxidation of the carbon backbone improves melt processing due to diminished crystallinity which also favors solution based processing due to improved solubility in common organic solvents. Order in a polymer backbone can be affected to increase crystallinity by substitution of the carbon backbone. Substitution of hydrogen atoms in a polyethylene (PE) backbone with fluorine and methyl group such as in Teflon® and poly(propylene) (PP), respectively, results in polymers that are highly crystalline and hence only processible at high temperatures and yield less pliable objects. Knowing these general trends will help in rationalizing the choice of polymers in various biomedical applications, which is discussed below.
In skeletal tissue replacement, excellent mechanical and structural characteristics are a prerequisite. Furthermore, in joint reconstruction such as total hip and knee replacement, synthetic polymers are used to fabricate the articulating surface, which also has a load bearing function. An artificial replacement therefore has to satisfy these two requirements. Since high density polyethylene (HDPE) and ultra high, molecular weight PE exhibit both good flexural and compressive modulus and a nominal coefficient of friction, they have seen extensive use in orthopaedic devices [3] . Since PE can be processed by injection molding, it allows for the easy fabrication of complex contoured objects such as joints. Although the wear-and-tear, characteristics are acceptable, local and systemic accumulation of PE particulate debris due to frictional erosion of the articulating surface can pose a potential long-term health risk [4] . Delrin® (DuPont), which is polyacetal derived from poly(oxymethylene) has also been explored as an alloplastic material in the reconstruction of mandibular joint [5] and in the fabrication of acetabular cups prosthesis [3] . Analysis on retrieved implants has shown that while the tissue response to PE and Delrin are similar, changes to implant surface properties were markedly different [6] . It was observed that in general, friction in recovered Delrin sockets was twice as that on PE sockets and the dimensional change was four times greater in the Delrin implants leading to a greater incidence of aseptic loosening of the implant [3] . Delrin is also used in the fabrication of heart valve occluders [7] . Extensive mechanical and structural analysis of Delrin heart valve and acetabular explants have found no evidence to support any in vivo degradation of the implant, which is indicative of good biostability [8] .
Poly(propylene) (PP), a methylated variant of PE has also seen use in several medical areas. Although its mechanical characteristics are not suitable for load bearing applications it has excellent fiber forming properties. PP meshes have been used as a prosthetic in the repair of abdominal defects (ventral incisional hernia) with superior clinical outcomes [9] [10] [11] . Recently, PP fibers have been explored in the delivery of tetracycline, an antimicrobial agent, to the root canal [12] . The Actisite® delivery system is currently approved by the US FDA for clinical use and represents the first periodontal drug delivery system. PP is also currently being used in malar and mandibular reconstruction [13] .
Fluorinated aliphatic polymers such as Teflon possess certain unique properties as the result of the highly polarized C-F bond along the backbone. Besides imparting very high crystallinity to the polymer, it also makes the surface very hydrophobic and lipophobic. This translates into a surface that is very resistant to fouling and truly neutral with respect to promoting or preventing biologically adverse interactions. When extruded under conditions of anisotropic loading, the micro architecture of Teflon exhibits pores that are axially aligned along the direction of stretching, resulting in a unique material with a microporous architecture. Extended-PTFE (e-PTFE) (Gore-Tex®) has very good permeability to oxygen and has found utility in several tissue-contacting applications. Gore-Tex meshes have been used as barriers in abdominal surgery to prevent unnatural adhesions [14, 15] . e-PTFE alloplasts have been used as barrier membranes in directing re-growth of bone in supraalveolar periodontal sites with moderate to good success [16] [17] [18] . Gore-Tex meshes have also been explored in the tension-free repair of ventral and incisional hernia [19] . Due its inert nature and tissue adhesivity, Teflon and e-PTFE are being used in orbital reconstruction [20] , facial reconstruction [21, 22] and rhinoplasty [23] [24] [25] . Teflon particles formulated as an injectable paste (STING, subureteric Teflon injection) are currently being used for the treatment of vesicoureteric reflux (VUR) in children with promising results [26] . GoreTex patches have been successfully employed to treat urinary incontinence due to urethral hypermobility in woman [27] . Teflon has also been explored in the development of artificial meniscus with a less than promising outcome [28] . Gore-Tex (e-PTFE) grafts have been used in graft-vein anastomosis with satisfactory clinical outcomes [29] , and are currently used in the fabrication of large diameter aortic and carotid vascular grafts. Dacron-a polyester derived from aromatic diacid and ethylene glycol (poly(ethylene terphthalate), (PET), is a slow degrading polymer that has become the material of choice for the fabrication of large diameter grafts. Knitted Dacron vascular grafts, has revolutionized cardiovascular surgery by offering a viable synthetic alternative to autologous transplantation and has
OH n been successfully used around the world for the past 15-20 years [30] . Like e-PTFE, Dacron meshes are also being used in abdominal wall reconstruction following a hernia procedure [9] . It is important to note that slow degrading polyamides, nylons, have also been successfully explored as meshes and are commonly used in the fabrication of sutures.
Poly(methylmethacrylate), PMMA which is derived from a photo-and chemically-curable monomer methylmethacrylate, has been used as a bone cement (sold under the trade name Palacos®) in the fixation and anchoring of artificial joints [31, 32] . PMMA has also been successfully explored in cranial reconstruction (cranioplasty) as a bone substitute [33] . One significant advantage of PMMA bone cement formulations over other synthetic bone substitutes is that its composition can be altered by the addition of bone promoting agents such as hydroxyapatite and other tri-calcium salts [34] . Although there are toxicity issues associated with long-term exposure to unreacted methacrylate monomer, the benefits conferred by its cementing properties far outweigh any risks [31] . The adverse effects of unreacted methacrylate monomer can be significantly diminished by using appropriate photoinitiators that promote 'dark curing', which is continued curing post-exposure to light radiation. In the past decade and a half, Palacos bone cement has also been explored as a vehicle for the localized drug delivery of gentamicin (Palamed®G), bacteriostatic agent for the treatment of osteomylitis [35, 36] .
Due to the lack of degradability, synthetic polymers can provide a diffusional barrier to small and large molecules. This property is a function of bulk polymer properties such as the glass transition temperature (Tg). Polymers that have Tg below or close to room temperature exhibit rubber like characteristics. The flexible nature of these polymers makes them ideally suited for implantable applications. Elvax and Silastic are two such polymers with an impressive history in drug delivery [37] .
Poly(dimethylsiloxane) (PDMS, silicone oil), and its cross-linked variants silicone rubber (without filler) and Silastic® (with silicon dioxide filler) have a long history in the medical field. The most successful drug delivery device to date, the Norplant® system, an implantable polymeric rod for the delivery of contraceptives (Levonorgestrel), is based on the barrier properties of Silastic® membrane [38, 39] . A single implant is capable of delivering the contraceptive agent at a steady rate for over three years. In this device, the Silastic serves as both the matrix for drug dispersion and the rate limiting barrier membrane. Besides drug delivery applications, Silastic has been extensively used in facial reconstructive surgery [40] and as orbital implant [20] . Silicone hydrogels have excellent optical and tissue contacting properties and are favored over PMMA as intraocular lenses [41, 42] . Due to its inertness in biological environments, Silastic tubing is used as the drain in the Ahmed drainage implant® or (Ahmed Glaucoma valve®), a FDA approved intraocular device for relieving intraocular pressure due to Glaucoma [43, 44] . In spite of the controversy surrounding the Silicone breast implants, the safety profile of this polymer is one of the best among all polymers in use today in medicine [37] . Elvax® (EVA), a copolymer of ethylene and vinyl acetate, has excellent film forming properties and due to its low Tg is very flexible at room temperature and has a good in vitro and in vivo safety profile [37] . EVA membranes are ideally suited as permeation barriers since by varying the monomer ratios in the co-polymer, the diffusion of small molecules can be altered. Implanon®, which is an implantable rod of EVA for the delivery of etonogestrel, is currently approved for clinical use in Europe and Canada and is awaiting approval in the United States, which is expected by 2004. EVA (Elvax) is also used as the rate limiting membrane in OCUSERT®, which is an ocular insert for the sustained release of Pilocarpine directly to the conjunctiva surface for the treatment of Glaucoma [45] . A variant of the Norplant system is the Nuvaring®, for the delivery of etonogestrel/ethinyl estradiol, which is a vaginal ring fabricated with Elvax for the delivery of contraceptives and is currently approved by the US FDA [46] .
Polymers that possess low Tg exhibit rubber like elasticity and are well suited for vascular applications wherein distensibility (elastic deformation) in a material is important to withstand the rigors and pressure variations of arterial circulation. Polyurethane (PU), which is derived by the copolymerization of a aromatic diisocyanate with a poly(alcohol), has a Tg below room temperature and hence is elastic in nature. PU's are slow degrading polymers that exhibit excellent blood compatibility due to their phaseseparated microstructure [47] . Since PTFE and Dacron surfaces are thrombogenic and relatively rigid, they are not suitable for the fabrication of small diameter vascular grafts [48] . PU has been proposed as a viable alternative as it is both haemocompatible and elastic [49, 50] . As improvements in PU stability are made, PU is being explored as coatings for biliary stents [51] and in hear valve prosthesis [52] .
Poly(ethyleneoxide) (PEO) (poly(ethyleneglycol), PEG), which belong to the class of aliphatic polyethers have been extensively explored as surface coatings for passivation of surfaces towards protein adsorption. The origins of protein inhibitory potential of PEG lie in steric exclusion effects due to the hydration and organization of water molecules around PEG chains [53] . This unique property of PEG has been exploited in improving protein stability, which is achieved by PEGylation of amino acid residues on proteins to preserve native protein conformation by inhibiting hydrophobic effects that lead to protein unfolding [54] . Poly(vinyl alcohol) (PVA), a aliphatic polyol and Pluronics®, which are block co-polymers of PEO and poly(propyleneoxide), are routinely used as emulsion stabilizers in the formulation of pharmaceuticals and particulate polymeric drug delivery systems such as nanoparticles and microspheres [55] . Their hydrogel forming properties is just beginning to be explored in the emerging areas of drug delivery and tissue engineering and is discussed in the following section.
EMERGING AND FUTURE USES
Although the erosion of PE surface upon cyclic loading is a concern, PE implants will continue to be used in the orthopaedic setting due to their excellent clinical performance. Creative solutions are being proposed to alter the mechanical properties of UHMWPE so as to reduce frictional wear. Merrill and co-workers have devised a novel approach to improve the wear resistance of UHMWPE by introducing a gradient of cross-linking in PE by exposing a PE melt to e-beam radiation [56] . This next generation implants have shown significantly improved performance in laboratory trails.
Both in dental and facial reconstruction, one can expect to see an increase in the use of e-PTFE in guided tissue regeneration as new biomolecules that are capable of directing specific tissue ingrowth are being identified. The bio-inertness of Teflon will continue to propel its use in tissue contacting applications such as meshes for abdominal surgery, biliary stents [57] , patches for aortoplasty in the treatment of coarctation of the aorta in children [58] , and the treatment of urinary incontinence [27] . In the coming years one can expect to see a exponential use of e-PTFE in emerging disciplines such as tissue engineering, where inertness of scaffold can prove vital in the presentation of information for cellular manipulation.
In addition, to its traditional uses, PMMA bone cement is increasing being used as a bone substitute in reconstructive procedures. Improved formulations with better curing characteristics (Copal®, Osteopal®) and loaded with bioactives (Palamed®G, Refobacin®-Palacos®) are already on the market. Some of the novel applications that have emerged in the recent past include cranioplasty and more recently vertebroplasty [59] [60] [61] . Vertebroplasty is a minimally invasive interventional therapy to alleviate pain associated with compression fracture. It involves injection of PMMA bone (Osteopal®V) cement to support the vertebral body and restore its height after osteoporotic compression fracture. In this setting, the bone cement behaves like a filler between two spinal processes, thereby stabilizing the fractured segments and alleviating the extreme pain associated with spinal compression fractures. Since the outcomes have been favorable, this procedure is fast gaining clinical acceptance. Nevertheless, toxicity associated with long-term exposure to unreacted methacrylate monomer will continue to be an issue of concern.
The prognosis for polymers such as Silastic and EVA (Elvax) in drug delivery applications is good. They will continue to be used as matrices in the long-term delivery of contraceptives, vaccines and other high-potency drugs that require controlled long-term delivery regimens. Surface modification approaches to improve long-term biocompatibility of these polymers will be key in realizing this potential. Silastic and Elvax may find uses in microelectro mechanical systems (MEMS) based drug delivery system as matrices for drug dispersion, wherein a single implantable device is capable of delivering a multitude of drugs in a preprogrammed fashion.
Beside its traditional use as a non-ionic surfactant in emulsification of polymer solutions in the fabrication of particulate delivery systems, PVA and Pluronics will continue to be explored for both topical and injectable applications. However, before that happens long-term safety of these polymers in an in vivo setting has to be established. These polymers offer a major advantage over Silastic and Elvax in that they are water-soluble and hence can be excreted from the body obviating the need for a retrieval procedure, as is the case with the Norplant system.
Although traditionally its has been assumed and suggested that degradability in a scaffold is of paramount importance in engineering of tissue replacement, this may not hold true for many tissue components where mechanical performance is an overriding factor. Examples of such tissue include skeletal components such as cartilage, tendon, ligaments and bone, and vascular prostheses. As tissue engineering matures into a discipline, with a focus more on 'functional tissue engineering', there is a compelling argument for the evaluation of hybrid tissue replacements. In a hybrid tissue equivalent (HTE), the permanent synthetic scaffold is designed to provide specific structural and mechanical characteristics to augment the evolving cellular component. In such a system, the role of cellular architecture will be to enhance the biocompatibility of the hybrid implant and ensure its integration with the host. In this context, synthetic non-degradable polymers such Teflon, PU, Silastic and PET will see an increased use as scaffolds in the ex-vivo engineering of tissue equivalents due to their specific mechanical characteristics. For example, poly(ethersulfones), which are traditionally used as hollow fibers for immobilization of enzymes in extra-corporeal devices [62, 63] , is being explored as guidance channels in peripheral nerve regeneration [64] . In the case of PU, any improvement in its long-term in vivo stability will significantly encourage its use in long-term implants such as small diameter vascular grafts. Similarly, gels derived from non-degradable soft-polymers such as PEG, PEO, Pluronic and PVA will be increasingly explored in the context of engineering of HTE. Currently, photocurable gels derived from PEO and PVA are being explored in the in vivo morphogenesis of cartilaginous tissue [65] .
CONCLUSIONS
Biodegradable polymers have an illustrious past in advancing the frontiers of medical science. Some of the greatest surgical advances would have been impossible without the non-degradable synthetic polymers. As we move into the 21 st century, emerging disciplines such as drug delivery and tissue engineering will play an increasingly central role in defining clinical treatment options. Nondegradable polymers, by virtue of their long association with the medical sciences, will continue to influence and shape these emerging fields. As we improve the tools for manipulating surfaces more precisely, biomolecular cues to control and dictate cellular behavior can be presented in a more meaningful fashion. In this context, the inertness of these polymers will be a vital asset in the evolution of the next generation of biomimetic drug delivery systems, implants and scaffolds.
